Get Premium Access

Medical Sales 101

Interview with Devin Hughes, EIR at CONNECT

Are you sick and tired of hearing the fluff from the self-proclaimed “sales gurus”? I can certainly empathize. I’ve been to a multitude of meetings and conferences only to walk away thinking, “I won’t be able to use any of that material in the least bit.” Well, Devin Hughes is much different. And that’s an understatement! Devin’s material is both highly practical and incredibly useful. Listen to the interview and I promise you won’t be disappointed!

Devin is currently an entrepreneur in residence at CONNECT, an independent non-profit organization that links high technology and life sciences entrepreneurs with the resources that they need for success: technology, money, markets, management, partners and support services. He also serves as an Executive Advisor at ODEXXO, a pioneer in the design and marketing of self-contained devices for specimen collecting and testing.

Interview Highlights with Devin Hughes

Devin’s personal pivot from the high-tech world to medical device sales.
One of my favorite quotes from Devin: “Get comfortable being uncomfortable.”
Understand the full patient journey.
Why you need and should take things personally.
The importance of working the night shift.
Find a different playbook…in order to get to a certain level of transparency.
Why the principle of “the doc likes me” doesn’t scale.

Premium Members Only

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

Become a Member

Already have an account? Sign in.

You May Like These Articles

Premium Content

Low Drama, High Performance, Big Results

Interview with PhotoniCare CEO Cary Vance

Cary Vance has been the Chairman, President, and CEO of PhotoniCare since May 2023. At PhotoniCare, his team developed the OtoSight Middle Ear Scope, a handheld device that enables healthcare providers to see through the eardrum to detect and assess middle-ear infections more accurately. In this interview, Cary shares why clinical evidence, workflow efficiency, and financial viability are the three pillars of medtech success and how he prepares for launches and M&As from day one.

Read Sample

Premium Content

Execution Beats Flashy Funding

Interview with AccurKardia CEO Juan C. Jimenez

Juan C. Jimenez is the co-founder and CEO of AccurKardia, a startup developing software that uses ECG data to help doctors detect heart conditions more accurately and efficiently with AI. In this interview, Juan talks about how to scale sustainably with optimal dilution, giving your team space to establish a solid product, forging authentic relationships with potential customers, and leveraging your credibility to move your business forward.

Read Sample

Premium Content

Thinking Global and Executing Local

Interview with Aether Biomedical CEO Dhruv Agrawal

Dhruv Agrawal is the CEO of Aether Biomedical, a startup developing advanced prosthetic solutions to improve accessibility and functionality for amputees. Their ZEUS bionic hand is a highly durable, multi-articulating prosthetic designed to handle everyday tasks with improved grip strength and resilience. Paired with a digital therapy platform, ZEUS enables end-to-end patient monitoring and support. In this interview, Dhruv discusses the importance of defining a clear problem statement, his approach to using grants to supplement VC funding, and the lessons he’s learned about evaluating market opportunities while operating globally.

Read Sample

Medsider Premium

Become a premium member and unlock access to exclusive Medsider benefits.

Unlock Full Access

Medsider Interviews

Low Drama, High Performance, Big Results

Interview with PhotoniCare CEO Cary Vance

Medsider Mentors

Medsider Playbooks

Playbook

A Guide to Widespread Adoption in Medtech

In medtech, developing novel, impactful technology is often just the starting line. The real race begins when you try to integrate your solution into the often-resistant healthcare system – a hurdle that has tripped up countless promising companies. Here are the key strategies and lessons from five veterans in the medtech space on how to overcome this hurdle.